Metabolites (May 2023)

Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson’s Disease—Preliminary Studies

  • Jan Milanowski,
  • Kamil Kozerawski,
  • Weronika Falęcka,
  • Dominik Dudek,
  • Beata Lisewska,
  • Paweł Lisewski,
  • Jarosław Nuszkiewicz,
  • Roland Wesołowski,
  • Jakub Wojtasik,
  • Celestyna Mila-Kierzenkowska,
  • Karolina Szewczyk-Golec

DOI
https://doi.org/10.3390/metabo13050668
Journal volume & issue
Vol. 13, no. 5
p. 668

Abstract

Read online

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases affecting elderly people. Considering the gap in the literature on melatonin and adipokine levels in PD patients at various stages of the disease, we conducted a study to investigate the levels of selected parameters in PD patients at the disease’s early (ES) and advanced (AS) stages. Melatonin, leptin, adiponectin, and resistin concentrations were measured in the blood serum of 20 PD patients without dyskinesia (ES), 24 PD patients with dyskinesia (AS), and 20 healthy volunteers as a control group (CG). The data were analyzed using ANOVA. Melatonin was significantly lower in ES (p p p p p p p p < 0.05) levels were found in AS versus ES. The main findings of the study include the changes in inflammatory markers’ levels during PD and a surprising increase in melatonin level in dyskinesia patients. Further research is necessary, which will be aimed at modulating the secretion of melatonin and adipokines as a treatment target for PD.

Keywords